20m
Biofrontera Inc (BFRI) reports significant clinical progress and cost reductions, despite weather-related shipment delays impacting Q3 revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback